Related Experiment Video

Updated: Aug 16, 2025

Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model
13:41

Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model

Published on: January 13, 2023

2.4K

RUNX1-Survivin Axis Is a Novel Therapeutic Target for Malignant Rhabdoid Tumors

Masamitsu Mikami1, Tatsuya Masuda2, Takuya Kanatani2

  • 1Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto 606-8303, Japan.

Molecules and Cells
|December 26, 2022
PubMed

Insights

Targeting the RUNX1-survivin axis shows promise for treating aggressive pediatric malignant rhabdoid tumors (MRT). Inhibiting RUNX1 reduces survivin, suppressing MRT cell proliferation in preclinical models.

Area of Science:

  • Pediatric Oncology
  • Molecular Biology
  • Cancer Therapeutics

Background:

  • Malignant rhabdoid tumor (MRT) is a rare and aggressive pediatric cancer lacking effective treatments.
  • Identifying novel therapeutic targets is crucial for developing effective anti-cancer strategies for MRT.

Purpose of the Study:

  • To investigate the role of the runt-related transcription factor 1 (RUNX1) and BIRC5/survivin axis in MRT proliferation.
  • To evaluate RUNX1 and survivin as potential therapeutic targets for MRT.

Main Methods:

  • Studied the interaction between RUNX1 and the survivin promoter in MRT cells.
  • Utilized RUNX1 knockdown and a novel RUNX inhibitor (Chb-M) in in vitro and in vivo MRT models.

Main Results:

  • RUNX1 positively regulates survivin expression, promoting MRT cell proliferation.
  • RUNX1 knockdown and Chb-M treatment decreased survivin levels and suppressed tumor growth.
  • Identified a novel RUNX1-survivin interaction critical for MRT progression.

Conclusions:

  • The RUNX1-survivin axis is a key driver of MRT proliferation.
  • Targeting RUNX1 activity represents a potential novel therapeutic strategy for malignant rhabdoid tumors.
Keywords:
RUNX1malignant rhabdoid tumorpolyamidesurvivin

More Related Videos

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas09:21

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas

Published on: September 13, 2019

7.2K
Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies09:29

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on: September 30, 2016

13.8K

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.2K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.3K